AwardedRomaniaGoodsFramework agreementRON 388,840,535
Furnizare antineoplazice, diverse medicamente
- Published
- Published 1 April 2026
- Deadline
- Closed 11 May 2026
Overview
The Oncology Institute Prof. Dr. I. Chiricuta in Cluj-Napoca procured diverse antineoplastic and other medications, with an estimated value of 388.8 million RON. The contract was awarded on 8 July 2026 for 319.0 million RON to a consortium of twelve suppliers including Alliance Healthcare România, B.Braun Medical, Unifarm, Dr.Max, Fresenius Kabi Romania, and others.
Key details
- Country
- Romania
- Status
- Awarded
- Category
- Goods
- Estimated value
- RON 388,840,535
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 1 April 2026
- Deadline
- Closed
Antineoplastic agentsVarious medicinal products
Award outcome
- Awarded value
- RON 319,024,852
- Award date
- 8 July 2026
- Contract period
- — → 16 December 2002
- ALLIANCE HEALTHCARE ROMNIA SRL
- B.BRAUN MEDICAL SRL
- BIO EEL S.R.L.
- COMPANIA NATIONALA UNIFARM
- DR.MAX
- FARMEXIM S.A.
- FILDAS TRADING S.R.L.
- FRESENIUS KABI ROMANIA SRL
- ROPHARMA S.A.
- RUBICON PHARMACEUTICALS SRL
- S.C. DONA.LOGISTICA S.R.L.
- SC PHARMA SA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
13 July 2026
Contract Award Notice
25 June 2026
Contract Notice
1 April 2026
Contracting authority
Institutul Oncologic Prof. Dr. I. Chiricuta Cluj-Napoca
Procuring entityCluj-Napoca, Romania
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.